Phibro Animal Health Corporation (PAHC) has officially completed its acquisition of Zoetis’ medicated feed additive product portfolio, along with selected water-soluble products. This finalized deal marks a significant expansion in Phibro’s nutritional and health solutions, giving them an enhanced product lineup that is positioned to deliver more targeted support for swine producers’ herd health and feed efficiency needs.
What This Means for Swine Producers
With the acquisition now complete, Phibro has added several specialized products to its existing portfolio, reinforcing its commitment to health and performance solutions in the swine sector. These products will help address growing demands for medicated feed additives that support swine health, growth, and productivity, especially in intensive production systems. Phibro’s broader range will give swine producers more options to control health challenges effectively, manage feed efficiency, and ultimately support herd productivity.
Building on Strategic Expansion
This acquisition follows months of strategic preparation and reflects Phibro’s intent to deliver a comprehensive suite of products across multiple species, including swine. By incorporating these additional Zoetis products, Phibro positions itself as a more versatile supplier, offering solutions that range from preventative care to therapeutic interventions within a unified portfolio.
Looking Ahead: Supporting Innovation in Medicated Feed Additives
With a commitment to innovation and sustainability, Phibro’s acquisition aligns with current trends in the industry toward improving animal health through precision nutrition and targeted interventions. Swine producers stand to benefit from Phibro’s expanded range as the company integrates these new products with their research-driven approach to product development and efficacy.
Continued Updates for Our Swine Web Community
Stay tuned as we bring more insights into how Phibro’s enhanced offerings can support producers in overcoming common health challenges. The successful completion of this acquisition marks an important milestone for the industry, providing expanded options that help producers meet their goals for both animal health and operational efficiency.
